Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Management of severe tardive dyskinesia induced by arpiprazole in a schizophrenic patient: a case report. | J Med Case Rep | 2026 | 42477822 | PubTator, text mining | PubMed |
| Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms. | EBioMedicine | 2026 | 42431745 | PubTator, text mining | PubMed |
| Structure-activity relationship of synthetic cathinones: integrated in silico, in vitro, and in vivo studies of α-PiHP analogues. | Arch Toxicol | 2026 | 42362749 | PubTator, text mining | PubMed |
| A diagnostic signature derived from NK cell related genes in prostate cancer: insights from integrated scRNA-seq and bulk RNA-seq analyses with functional validation of KIT. | Front Immunol | 2026 | 42317356 | PubTator, text mining | PubMed |
| Multimodal Imaging Reveals Rapid Catecholamine Uptake and Release by Neutrophils. | Adv Sci (Weinh) | 2026 | 42314056 | PubTator, text mining | PubMed |
| The genetic landscape of childhood-onset dystonia in a nationwide Turkish cohort: Clinical spectrum, molecular diagnostics, and therapeutic implications. | Eur J Paediatr Neurol | 2026 | 42308683 | PubTator, text mining | PubMed |
| Maternal obesity and inadequate gestational weight gain disrupts placental dopaminergic signaling: impact on infant neurodevelopment. | Front Endocrinol (Lausanne) | 2026 | 42267298 | PubTator, text mining | PubMed |
| Efficacy and Safety of Deutetrabenazine in Tourette Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Psychopharmacol Bull | 2026 | 42267238 | PubTator, text mining | PubMed |
| Case Report: Two siblings with a novel homozygous SLC18A2 variant causing parkinsonism-dystonia-2: a case series from Saudi Arabia. | Front Genet | 2026 | 42245405 | PubTator, text mining | PubMed |
| ALDH1A1-dopaminergic gene co-expression in human substantia nigra: meta-analysis of disease-associated correlation changes across seven independent Parkinson's disease datasets. | Front Aging Neurosci | 2026 | 42239820 | PubTator, text mining | PubMed |
| SOM3355: a unique pharmacological profile combining VMAT1 inhibition, VMAT2-mediated dopamine modulation, and β1-adrenergic antagonism for the treatment of movement and neuropsychiatric disorders. | Front Pharmacol | 2026 | 42239508 | PubTator, text mining | PubMed |
| Toxicity and risk after using new modalities of radiotherapy in Algeria: retrospective intercomparison study. | Radiat Prot Dosimetry | 2026 | 42233309 | PubTator, text mining | PubMed |
| Neurexins contribute to inhibitory connectivity and dopamine neuron resilience in culture. | Neuroscience | 2026 | 42162731 | PubTator, text mining | PubMed |
| Tetrabenazine-Responsive Choreo-Ballism and Akathisia After Cardioversion and Coronary Angiography: A Case Report. | Cureus | 2026 | 42099367 | PubTator, text mining | PubMed |
| Dynamic brain states and molecular signatures in primary angle-closure glaucoma. | Neuroreport | 2026 | 42066007 | PubTator, text mining | PubMed |
| Toxicological and forensic aspects of a fatal 3-methylmethcathinone intoxication: A case report. | J Forensic Leg Med | 2026 | 42013732 | PubTator, text mining | PubMed |
| Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation. | Psychiatry Clin Neurosci | 2026 | 41947298 | PubTator, text mining | PubMed |
| Amantadine as an Alternative to VMAT2 Inhibitors for Tardive Dyskinesia in Patients at Risk of Depression and Suicidality: A Case Report. | J Clin Psychopharmacol | 2026 | 41928712 | PubTator, text mining | PubMed |
| Neurotransmitter Systems in Alzheimer's Disease. | Curr Issues Mol Biol | 2026 | 41899485 | PubTator, text mining | PubMed |
| Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions. | Clin Pharmacol Drug Dev | 2026 | 41866636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=2